Drug Management in End-of-Life Hospitalized Palliative Care Cancer Patients: The RHESO Cohort Study.

CONCLUSIONS: NACT prescription remained commonplace in terminally ill palliative cancer patients, although their benefit is questionable.
PMID: 31220846 [PubMed - as supplied by publisher]

Source: Oncology - June 19, 2019 Category: Cancer & Oncology Authors: Vallard A, Morisson S, Tinquaut F, Chauvin F, Oriol M, Chapelle C, Sotton S, Magné N, Tardy B, Bourmaud A Tags: Oncology Source Type: research